{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T17:59:36Z","timestamp":1760983176692},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Therapy"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s12325-009-0052-3","type":"journal-article","created":{"date-parts":[[2009,7,31]],"date-time":"2009-07-31T00:51:04Z","timestamp":1249001464000},"page":"711-718","source":"Crossref","is-referenced-by-count":10,"title":["Dyslipidemia therapy update: the importance of full lipid profile assessment"],"prefix":"10.1007","volume":"26","author":[{"given":"I. B. A.","family":"Menown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Murtagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. T.","family":"Cooney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I. M.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Tomkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,7,27]]},"reference":[{"issue":"suppl.2","key":"52_CR1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/01.hjr.0000277983.23934.c9","volume":"14","author":"I. Graham","year":"2007","unstructured":"Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Eur J Cardiovasc Prev Rehabil. 2007;14(suppl. 2):S1\u2013S113.","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"key":"52_CR2","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"Third Report of the National Cholesterol Education Program","year":"2002","unstructured":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143\u20133421.","journal-title":"Circulation"},{"issue":"suppl.5","key":"52_CR3","first-page":"1","volume":"91","author":"British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association.","year":"2005","unstructured":"British Cardiac Society, British Hypertension Society, Diabetes UK, HEART UK, Primary Care Cardiovascular Society, Stroke Association. JBS 2: Joint British Societies\u2019 guidelines on prevention of cardiovascular disease in clinical practice. Heart. 2005; 91(suppl. 5):1\u201352.","journal-title":"Heart"},{"key":"52_CR4","first-page":"11","volume":"9","author":"Menown IBA.","year":"2006","unstructured":"Menown IBA. HDL cholesterol \u2014 a new target for cardiovascular intervention. Cardiol News. 2006;9:11\u201313.","journal-title":"Cardiol News."},{"key":"52_CR5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9149(91)90742-4","volume":"68","author":"G.S. Ginsburg","year":"1991","unstructured":"Ginsburg GS, Safran C, Pasternak RC. Frequency of low serum high-density lipoprotein cholesterol levels in hospitalized patients with \u201cdesirable\u201d total cholesterol levels. Am J Cardiol. 1991;68:187\u2013192.","journal-title":"Am J Cardiol."},{"key":"52_CR6","first-page":"207","volume":"8","author":"R.D. Abbott","year":"1988","unstructured":"Abbott RD, Wilson PW, Kannel WB, Castelli WP. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham study. Arteriosclerosis. 1988;8:207\u2013211.","journal-title":"The Framingham study. Arteriosclerosis."},{"key":"52_CR7","unstructured":"Murtagh G, Kiernan TJ, Tekle S, Boran G, Maher V. Isolated cholesterol measurements hide significant lipid abnormalities. Paper presented at: Irish Atherosclerosis Society; October 11, 2008; Galway, Ireland."},{"key":"52_CR8","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1016\/0021-9150(96)05852-2","volume":"124","author":"G. Assmann","year":"1996","unstructured":"Assmann G, Schulte H, von Eckardstein A, Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. Atherosclerosis. 1996;124:S11\u2013S20.","journal-title":"Atherosclerosis."},{"key":"52_CR9","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","volume":"24","author":"R.M. Conroy","year":"2003","unstructured":"Conroy RM, Py\u00f6r\u00e4l\u00e4 K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987\u20131003.","journal-title":"Eur Heart J."},{"key":"52_CR10","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.298.7.776","volume":"298","author":"E. Ingelsson","year":"2007","unstructured":"Ingelsson E, Schaefer EJ, Contois JH, et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA. 2007;298:776\u2013785.","journal-title":"JAMA."},{"key":"52_CR11","unstructured":"Cooney MT, Dudina A, Graham I. SCORE HDL \u2014 incorporation of HDL into risk estimation. Paper presented at: Irish Atherosclerosis Society; October 11, 2008; Galway, Ireland."},{"key":"52_CR12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"M.J. Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27: 157\u2013172.","journal-title":"Stat Med."},{"key":"52_CR13","first-page":"1399","volume-title":"Oxford Textbook of Medicine","author":"P.N. Durrington","year":"1996","unstructured":"Durrington PN. Lipid and lipoprotein disorders. In: Weatherall DJ, Ledingham JGG, Warrell DA, eds. Oxford Textbook of Medicine. Oxford: Oxford University Press; 1996:1399\u20131415."},{"key":"52_CR14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0021-9150(93)90083-7","volume":"102","author":"V.M.G. Maher","year":"1993","unstructured":"Maher VMG, Gallagher JJ, Myant NB. The binding of very-low-density lipoprotein remnants to the low-density lipoprotein receptor in patients with familial defective apolipoprotein B-100. Atherosclerosis. 1993;102:51\u201361.","journal-title":"Atherosclerosis."},{"key":"52_CR15","first-page":"304","volume":"18","author":"S. Kokolis","year":"2006","unstructured":"Kokolis S, Marmur JD, Clark LT, et al. Effects of alcoholism on coronary artery disease and left ventricular dysfunction in male veterans. J Invasive Cardiol. 2006;18:304\u2013307.","journal-title":"J Invasive Cardiol."},{"key":"52_CR16","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1161\/01.ATV.3.4.316","volume":"3","author":"G.G. Rhoads","year":"1983","unstructured":"Rhoads GG, Feinleib M. Honolulu Heart Study. Arteriosclerosis. 1983;3:316\u2013322.","journal-title":"Arteriosclerosis."},{"key":"52_CR17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/0002-9149(92)90550-I","volume":"70","author":"G. Assmann","year":"1992","unstructured":"Assmann G, Schulte H. Prospective Cardiovascular M\u00fcnster Study. Am J Cardiol. 1992;70:733\u2013737.","journal-title":"Am J Cardiol."},{"key":"52_CR18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1001\/jama.1988.03410050061031","volume":"260","author":"V. Manninen","year":"1988","unstructured":"Manninen V, Elo MO, Frick MH, et al. Lipid alterations and decline in the incidence of coronary heart disease in the Helsinki Heart Study. JAMA. 1988;260:641\u2013651.","journal-title":"JAMA."},{"key":"52_CR19","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1161\/CIRCULATIONAHA.106.676379","volume":"116","author":"B. Balkau","year":"2007","unstructured":"Balkau B, Deanfield JD, Despres J-P, et al. International day for the evaluation of abdominal obesity (IDEA). Circulation. 2007;116:1941\u20131951.","journal-title":"Circulation."},{"key":"52_CR20","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1007\/s00125-003-1141-5","volume":"46","author":"G. Bos","year":"2003","unstructured":"Bos G, Dekker JM, Nijpels G, et al. A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism \u2014 the Hoorn study. Diabetologia. 2003;46:910\u2013916.","journal-title":"Diabetologia."},{"key":"52_CR21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.298.3.309","volume":"298","author":"S. Bansal","year":"2007","unstructured":"Bansal S, Buring JE, Rifai N, et al. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA. 2007;298:309\u2013316.","journal-title":"JAMA."},{"key":"52_CR22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","volume":"298","author":"B.G. Nordestgaard","year":"2007","unstructured":"Nordestgaard BG, Benn M, Schnohr P, Tybjaerg-Hansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA. 2007;298:299\u2013308.","journal-title":"JAMA."},{"key":"52_CR23","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S0140-6736(00)04209-4","volume":"357","author":"Diabetes Atherosclerosis Intervention Study Investigators.","year":"2001","unstructured":"Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet. 2001;357:905\u2013909.","journal-title":"Lancet."},{"key":"52_CR24","first-page":"S3","volume":"15","author":"G. Muragasu","year":"1998","unstructured":"Muragasu G, Phillips C, Owens D, Collins P, Johnson A, Tomkin GH. Effect of improvement in glycaemic control on apo B48 and post-prandial lipoproteins in non-insulin-dependent diabetes. Diabet Med. 1998;15:S3.","journal-title":"Diabet Med."},{"key":"52_CR25","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2362.1998.00317.x","volume":"28","author":"S.D. Proctor","year":"1998","unstructured":"Proctor SD, Mamo JC. Retention of fluorescentlabelled chylomicron remnants within the intima of the arterial wall \u2014 evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest. 1998;28:497\u2013503.","journal-title":"Eur J Clin Invest."},{"key":"52_CR26","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","volume":"46","author":"M.R. Taskinen","year":"2003","unstructured":"Taskinen MR. Diabetic dyslipidaemia: from basic research to clinical practice. Diabetologia. 2003;46:733\u2013749.","journal-title":"Diabetologia."}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0052-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-009-0052-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-009-0052-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:55:55Z","timestamp":1559447755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-009-0052-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1007\/s12325-009-0052-3","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}